MedTrace Logo

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas

NCT05947084 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 518

Last updated 2025-07-02

No results posted yet for this study

Summary

A 4 month growth monitoring study of healthy term infants fed iron fortified infant formula. Infants will be fed ad-libitum for 16 weeks and growth will be evaluated in terms of weight gain over the 16 weeks.

Conditions

  • Infant Development

Interventions

OTHER

Infant Formula

Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period

Sponsors & Collaborators

  • Validcare

    collaborator UNKNOWN

  • Aussie Bubs, Inc.

    lead INDUSTRY

Principal Investigators

  • Keith Aqua, MD · Backtee Holdings, LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2025-04-19
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947084 on ClinicalTrials.gov